Pancreatic Cancer Research

ResearcherYanbian UniversityActive in the last 2 years

Zhenhua Lin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0279-3166; OpenAlex author ID A5101690705. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
14
Papers, trials and grants by year

2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper

Papers 7

  1. Rosuvastatin inhibits carcinogenesis through Ca2+ triggered endoplasmic reticulum stress pathway in pancreatic cancer. Co-author DOI 10.1016/j.cellsig.2025.111753↗
  2. The CPT1A/Snail axis promotes pancreatic adenocarcinoma progression and metastasis by activating the glycolytic pathway. Co-author DOI 10.1016/j.isci.2023.107869↗
  3. miR-590-5p/Tiam1-mediated glucose metabolism promotes malignant evolution of pancreatic cancer by regulating SLC2A3 stability. Last author DOI 10.1186/s12935-023-03159-3↗
  4. HSDL2 Acts as a Promoter in Pancreatic Cancer by Regulating Cell Proliferation and Lipid Metabolism. Co-author DOI 10.2147/ott.s287722↗
  5. Elevated expression of Tiam1 is associated with poor prognosis and promotes tumor progression in pancreatic cancer. Co-author DOI 10.2147/ott.s171425↗
  6. Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma. Last author DOI 10.3892/ol.2017.5821↗
  7. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Last author DOI 10.3892/or.2016.5302↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anna Han · 2 shared papers, 2021–2023 · strength 0.36
  2. Aihua Jin · 3 shared papers, 2017–2023 · strength 0.36
  3. Hui Miao · 1 shared paper, 2025 · strength 0.28
  4. Yanqun Liu · 1 shared paper, 2025 · strength 0.28
  5. Shipeng Yang · 1 shared paper, 2023 · strength 0.20
  6. Yang Yang · 1 shared paper, 2023 · strength 0.20
  7. Ying Liu · 1 shared paper, 2023 · strength 0.20
  8. Yang Yang · 2 shared papers, 2017–2018 · strength 0.17
  9. Liyan Chen · 2 shared papers, 2017–2018 · strength 0.17
  10. Wan-Shan Yang · 1 shared paper, 2021 · strength 0.16
  11. Jie Lena Sun · 2 shared papers, 2017 · strength 0.15
  12. Mina Ding · 1 shared paper, 2018 · strength 0.09
  13. Meiying Ji · 1 shared paper, 2017 · strength 0.08
  14. Xuelian Cui · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.